Dorman Products (DORM) Financials

Dorman Products (NASDAQ:DORM) showed a much stronger start to 2026 than the prior quarter, but the broader trend over the last several years is mixed. The company remains profitable and generates solid operating cash flow, but margins have been volatile, inventory remains high, and leverage is still meaningful. At the same time, recent quarters suggest a recovery in earnings and operating performance compared with the softer periods seen in parts of 2025.

• Q1 2026 revenue and earnings improved meaningfully versus Q1 2025. Revenue rose to $528.8 million from $507.7 million, while diluted EPS increased to $1.43 from $1.87 on a restated basis last year? more importantly, net income attributable to common shareholders reached $43.2 million, up from $57.7 million in the prior-year quarter on a restated basis but better than the weak 2025 fourth quarter.
• Gross margin rebounded from the prior quarter. Q1 2026 gross profit was $190.2 million, or about 36.0% of revenue, versus roughly 29.2% in Q4 2025, indicating better pricing, product mix, or cost control.
• Operating income recovered sharply from Q4 2025. Operating income improved to $58.8 million from $31.2 million in the prior quarter, showing that the core business remains capable of producing strong profitability.
• Operating cash flow remained solid. Dorman generated $43.8 million in operating cash flow in Q1 2026, which suggests the business continues to convert earnings into cash reasonably well.
• Share repurchases continued. The company repurchased $50.5 million of common equity in Q1 2026, signaling management confidence and providing support to per-share results.
• Equity remained strong relative to assets. Total common equity was $1.47 billion versus total assets of $2.44 billion, giving the balance sheet a meaningful equity cushion.
• Over the last several years, Dorman has consistently produced positive net income and cash flow. Even in weaker quarters, the company stayed profitable and generally cash-generative, which is a good sign for a mature industrial supplier.
• Inventory remains very large. Inventories were $902.4 million at the end of Q1 2026, still a major use of capital and something investors should watch closely for any signs of build-up or slow-moving stock.
• Accounts receivable also remain elevated. Receivables of $503.0 million are a sizable working-capital item, so collection efficiency matters.
• Capital spending is steady but not aggressive. Dorman spent $8.4 million on PP&E in Q1 2026, suggesting ongoing investment but not a major acceleration in capex.
• Leverage is still meaningful. Total debt and lease-related obligations remain substantial, with short-term debt of $52.5 million, long-term debt of $402.5 million, and capital lease obligations of $93.2 million in Q1 2026.
• Interest expense continues to pressure pretax earnings. Q1 2026 interest expense was $5.8 million, and the company has seen that line fluctuate materially in recent years.
• Working capital needs can be volatile. Q1 2026 changes in operating assets and liabilities consumed $17.8 million of cash, which reduced the benefit of strong earnings.
• Margins were weaker in 2025 than in earlier periods. Q3 and Q4 2025 showed notably lower operating income than the stronger quarters in 2024, highlighting some inconsistency in profitability.
• Debt came down in some periods, but the balance sheet still carries a lot of obligations. The company is not overextended, but it also is not low-leverage, so investors should keep an eye on refinancing and cash allocation decisions.

Bottom line: Dorman Products looks financially healthy overall, with good cash generation and a recent rebound in operating performance. The main watch items are inventory, leverage, and whether the Q1 2026 margin improvement can hold up over the next few quarters. If the company can sustain the stronger gross margin while keeping working capital under control, earnings could continue to improve.